CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 27 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all existing business lines.
1996
300K+
LTM Revenue $379B
LTM EBITDA $15.3B
$150B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
CVS Health has a last 12-month revenue (LTM) of $379B and a last 12-month EBITDA of $15.3B.
In the most recent fiscal year, CVS Health achieved revenue of $373B and an EBITDA of $13.7B.
CVS Health expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See CVS Health valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $379B | XXX | $373B | XXX | XXX | XXX |
Gross Profit | $158B | XXX | $51.4B | XXX | XXX | XXX |
Gross Margin | 42% | XXX | 14% | XXX | XXX | XXX |
EBITDA | $15.3B | XXX | $13.7B | XXX | XXX | XXX |
EBITDA Margin | 4% | XXX | 4% | XXX | XXX | XXX |
EBIT | $12.6B | XXX | $9.8B | XXX | XXX | XXX |
EBIT Margin | 3% | XXX | 3% | XXX | XXX | XXX |
Net Profit | $5.0B | XXX | $4.6B | XXX | XXX | XXX |
Net Margin | 1% | XXX | 1% | XXX | XXX | XXX |
Net Debt | XXX | XXX | $57.7B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, CVS Health's stock price is $64.
CVS Health has current market cap of $81.0B, and EV of $150B.
See CVS Health trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$150B | $81.0B | XXX | XXX | XXX | XXX | $5.71 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, CVS Health has market cap of $81.0B and EV of $150B.
CVS Health's trades at 0.4x EV/Revenue multiple, and 10.9x EV/EBITDA.
Equity research analysts estimate CVS Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
CVS Health has a P/E ratio of 16.3x.
See valuation multiples for CVS Health and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $81.0B | XXX | $81.0B | XXX | XXX | XXX |
EV (current) | $150B | XXX | $150B | XXX | XXX | XXX |
EV/Revenue | 0.4x | XXX | 0.4x | XXX | XXX | XXX |
EV/EBITDA | 9.8x | XXX | 10.9x | XXX | XXX | XXX |
EV/EBIT | 11.9x | XXX | 15.3x | XXX | XXX | XXX |
EV/Gross Profit | 0.9x | XXX | n/a | XXX | XXX | XXX |
P/E | 16.3x | XXX | 17.6x | XXX | XXX | XXX |
EV/FCF | 21.3x | XXX | 23.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCVS Health's last 12 month revenue growth is 4%
CVS Health's revenue per employee in the last FY averaged $1.2M, while opex per employee averaged $0.1M for the same period.
CVS Health's rule of 40 is 9% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
CVS Health's rule of X is 14% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for CVS Health and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | 4% | XXX | 4% | XXX | XXX | XXX |
EBITDA Margin | 4% | XXX | 4% | XXX | XXX | XXX |
EBITDA Growth | 9% | XXX | -6% | XXX | XXX | XXX |
Rule of 40 | 9% | XXX | 8% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | 14% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $1.2M | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 11% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
SC Ropharma | XXX | XXX | XXX | XXX | XXX | XXX |
Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
CVS Health acquired XXX companies to date.
Last acquisition by CVS Health was XXXXXXXX, XXXXX XXXXX XXXXXX . CVS Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was CVS Health founded? | CVS Health was founded in 1996. |
Where is CVS Health headquartered? | CVS Health is headquartered in United States of America. |
How many employees does CVS Health have? | As of today, CVS Health has 300K+ employees. |
Who is the CEO of CVS Health? | CVS Health's CEO is Mr. J. David Joyner. |
Is CVS Health publicy listed? | Yes, CVS Health is a public company listed on NYS. |
What is the stock symbol of CVS Health? | CVS Health trades under CVS ticker. |
When did CVS Health go public? | CVS Health went public in 1952. |
Who are competitors of CVS Health? | Similar companies to CVS Health include e.g. MedPlus India, SC Ropharma, Pague Menos, Droga Raia. |
What is the current market cap of CVS Health? | CVS Health's current market cap is $81.0B |
What is the current revenue of CVS Health? | CVS Health's last 12 months revenue is $379B. |
What is the current revenue growth of CVS Health? | CVS Health revenue growth (NTM/LTM) is 4%. |
What is the current EV/Revenue multiple of CVS Health? | Current revenue multiple of CVS Health is 0.4x. |
Is CVS Health profitable? | Yes, CVS Health is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of CVS Health? | CVS Health's last 12 months EBITDA is $15.3B. |
What is CVS Health's EBITDA margin? | CVS Health's last 12 months EBITDA margin is 4%. |
What is the current EV/EBITDA multiple of CVS Health? | Current EBITDA multiple of CVS Health is 9.8x. |
What is the current FCF of CVS Health? | CVS Health's last 12 months FCF is $7.0B. |
What is CVS Health's FCF margin? | CVS Health's last 12 months FCF margin is 2%. |
What is the current EV/FCF multiple of CVS Health? | Current FCF multiple of CVS Health is 21.3x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.